Table 2.
Association of inflammatory biomarkers with LV mass index in the total study population.
Univariable | Model 1 a | Model 2 b | Model 3 c | |||||
---|---|---|---|---|---|---|---|---|
β | p | β | p | β | p | β | p | |
SAA, µg/ml | 0.16 | .05 | 0.17 | .04 | 0.13 | .09 | 0.18 | .02 |
CRP, µg/ml | 0.07 | .41 | 0.06 | .44 | 0.04 | .61 | 0.06 | .48 |
Neopterin, nmol/L | 0.03 | .69 | 0.01 | .86 | 0.08 | .29 | 0.11 | .17 |
KTR, nmol/µmol | 0.18 | .03 | 0.20 | .02 | 0.19 | .01 | 0.20 | .02 |
PAr index | 0.26 | .002 | 0.27 | .001 | 0.26 | .001 | 0.26 | .002 |
The association between each inflammatory marker and LV mass index was tested in separate multivariable models adjusted for aage and sex; bage, sex, psoriasis, body mass index, hypertension; cage, sex, psoriasis, body mass index, hypertension, smoking, kidney function.
CRP: C-reactive protein; KTR: kynurenine:tryptophan ratio; LV: left ventricular; PAr: pyridoxic acid ratio; SAA: serum amyloid A.